+44-15180811362025: Volume 8, Issue 3
Mini Review P.1-1
Pharmacovigilance in the Era of Biologics and Biosimilars: Challenges and Solutions
Author(s):
Fatima Khan
DOI: 10.35841/aajcrp.7.3.186
Opinion Article P.1-1
Optimizing drug bioavailability: Multi-faceted strategies
Author(s):
Michael Adams
DOI: 10.35841/aajcrp.7.3.187
Opinion Article P.1-1
Herbal medicine: Diverse therapeutic potential
Author(s):
Chen Wei
DOI: 10.35841/aajcrp.7.3.188
Mini Review P.1-1
Tdm: Optimizing dosing, improving patient outcomes
Author(s):
Lucia Romano
DOI: 10.35841/aajcrp.7.3.189
Rapid Communication P.1-1
Drug delivery systems: Evolution and innovation
Author(s):
Ethan Collins
DOI: 10.35841/aajcrp.7.3.190
Mini Review P.1-1
Nanopharmaceuticals: Revolutionizing medicine, addressing key challenges
Author(s):
Hye-Jin Park
DOI: 10.35841/aajcrp.7.3.191
Perspective P.1-1
Pharmacoeconomic evaluations of healthcare innovations
Author(s):
Catherine Osei
DOI: 10.35841/aajcrp.7.3.192
Opinion Article P.1-1
Pharmacoeconomics: Rwe, hta, evaluating innovation, sustainability
Author(s):
Catherine Osei
DOI: 10.35841/aajcrp.7.3.193
Short Communication P.1-1
Evolving drug development: Innovative methodologies
Author(s):
Li Wei
DOI: 10.35841/aajcrp.7.3.194
Mini Review P.1-1
Tdm: Optimizing dosing for personalized medicine
Author(s):
Lucia Romano
DOI: 10.35841/aajcrp.7.3.195